Think In Pink Tuesday 21 September, 2010

Tweet OPI Pink of Hearts 2010 Nail Lacquer to Benefit Rethink Breast Cancer For a fourth year, OPI has created a Pink of Hearts Nail Lacquer to support Rethink Breast Cancer in its promise to support young people concerned about and affected by breast cancer. The 2010 edition of Pink of Hearts will follow in [...]
OPI Pink of Hearts 2010 Nail Lacquer
to Benefit Rethink Breast Cancer
For a fourth year, OPI has created a Pink of Hearts Nail Lacquer to support Rethink Breast Cancer in its promise to support young people concerned about and affected by breast cancer. The 2010 edition of Pink of Hearts will follow in the footsteps of its namesake 2007, 2008 and 2009 Nail Lacquers in raising awareness of breast cancer during the month of October
(National Breast Cancer Awareness Month). Additionally, OPI will be once again making a donation of $5,000 to Rethink Breast Cancer. “As the fight against breast cancer wages on, Rethink Breast Cancer has remained committed to help find the cure,” says Suzi Weiss-Fischmann, OPI Executive VP & Artistic Director. “OPI is proud to join with Rethink for the fourth consecutive year, with Pink of Hearts 2010 Edition. It is OPI’s way to support the effort to end this disease, to honour those affected by it, and to give all women the power to help make a difference.” Pink of Hearts 2010 Edition is an empowering light pink – a colour designed specifically to inspire and uplift. Each bottle has a special pink-ribbon cap wrap in support of breast cancer awareness. Pink of Hearts contains no DBP, Toluene, or Formaldehyde, and features the exclusive OPI ProWide™ Brush for the ultimate in smooth, streak-free application.
Pink of Hearts 2010 Edition will be available October 2010 at
Professional Salons and Spas for $10.95 (CAN) suggested retail for each Nail
Lacquer. For more information about OPI, please call 800-341-9999 or visit
www.opi.com. For more information about Rethink Breast Cancer, please
visit www.rethinkbreastcancer.com.





There are no comments yet, add one below.